Edvince
Share:
Subscribe:
news.cision.com
/
Edvince
/
Edvince AB was granted FDA Orphan-Drug Designation for EDV2209 in treatment of subarachnoid hemorrhage
/
EDVINCE-LOGO-160830
EDVINCE-LOGO-160830
Thu, Aug 10, 2017 10:19 CET
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
Edvince AB was granted FDA Orphan-Drug Designation for EDV2209 in treatment of subarachnoid hemorrhage
Thu, Aug 10, 2017 10:19 CET
